Treatment of vinorelbine-associated tumor pain

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 4, 2001, Pages 414-415

  Long, Teresa D ^a   Twillman, Robert K ^b   Cathers Schiffman, Teresa A ^a   O'Donnell, Teri ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

Ketorolac; Pain; Vinorelbine

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; HYDROMORPHONE; KETOROLAC; MORPHINE; NAVELBINE; PACLITAXEL;

ADULT; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL ARTICLE; DRUG INFUSION; FEMALE; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; UTERINE CERVIX CANCER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE NEOPLASMS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETOROLAC; MIDDLE AGED; PAIN; VINBLASTINE;

EID: 0034908356     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200108000-00023     Document Type: Article

References (4)

1. A summary of vinorelbine (Navelbine) safety data from North American clinical trials
2. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck
3. Acute tumor pain in patients with head and neck cancer treated with vinorelbine [letter]
4. Pain at tumor site after vinorelbine injection: Description of an unexpected side effect